ST14 anticorps (N-Term)
Aperçu rapide pour ST14 anticorps (N-Term) (ABIN615862)
Antigène
Voir toutes ST14 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- This antibody reacts to the N-term of Suppression Of Tumorigenicity 14 (colon Carcinoma, Matriptase, Epithin) (ST14).
-
Purification
- Immunoaffinity Chromatography
-
Immunogène
- ST14 antibody was raised against synthetic peptide - KLH conjugated Genename: ST14
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1,0 mg/mL
-
Buffer
- PBS (without Mg2+, Ca2+), pH 7.4 containing 150 mM sodium chloride, 0.02 % sodium azide as preservative and 50 % glycerol as stabilizer
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
-
- ST14 (Suppression of Tumorigenicity 14 (ST14))
-
Autre désignation
- ST14 / Matriptase
-
Sujet
- Synonyms: Membrane-type serine protease 1, PRSS14, Prostamin, SNC19, Serine protease 14, Serine protease TADG-15, Suppressor of tumorigenicity 14 protein, T-SP1, TADG15, Tumor-associated differentially-expressed gene 15 protein
-
ID gène
- 6768
-
NCBI Accession
- NP_068813
-
UniProt
- Q9Y5Y6
Antigène
-